- Filed
- Sep 24, 2015 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2015 · May 20, 2015 | 4.85M sh |
| Shares Diluted | Q1 2015 · Mar 31, 2015 | 3.82M sh |
| Shares Diluted restated | Q1 2015 · Mar 31, 2014 | 3.33M sh |
| Cash And Equivalents | Q1 2015 · Mar 31, 2015 | $113.29K |
| Cash And Equivalents | Q1 2015 · Dec 31, 2014 | $72.17K |
| Cash And Equivalents | Q1 2015 · Mar 31, 2014 | $12.54K |
| Cash And Equivalents | Q1 2015 · Dec 31, 2013 | $17.7K |
| Stockholders Equity restated | Q1 2015 · Mar 31, 2015 | −$1.74M |
| Stockholders Equity restated | Q1 2015 · Dec 31, 2014 | −$1.56M |
| Current Liabilities restated | Q1 2015 · Mar 31, 2015 | $12.19M |
| Current Liabilities restated | Q1 2015 · Dec 31, 2014 | $11.36M |
| Total Liabilities restated | Q1 2015 · Mar 31, 2015 | $21.04M |
| Total Liabilities restated | Q1 2015 · Dec 31, 2014 | $21.42M |
| Current Assets | Q1 2015 · Mar 31, 2015 | $2.38M |
| Current Assets | Q1 2015 · Dec 31, 2014 | $2.71M |
| Total Assets restated | Q1 2015 · Mar 31, 2015 | $19.3M |
| Total Assets restated | Q1 2015 · Dec 31, 2014 | $19.86M |
| Eps Diluted restated | Q1 2015 · Mar 31, 2015 | −$0.07 |
| Eps Diluted restated | Q1 2015 · Mar 31, 2014 | $0.45 |
| Eps Basic restated | Q1 2015 · Mar 31, 2015 | −$0.07 |
| Eps Basic restated | Q1 2015 · Mar 31, 2014 | $0.48 |
| Sga Expense restated | Q1 2015 · Mar 31, 2015 | $195.69K |
| Sga Expense restated | Q1 2015 · Mar 31, 2014 | $263.87K |
| Net Income restated | Q1 2015 · Mar 31, 2015 | −$270.44K |
| Net Income restated | Q1 2015 · Mar 31, 2014 | $1.5M |
| Operating Income restated | Q1 2015 · Mar 31, 2015 | $742.65K |
| Operating Income restated | Q1 2015 · Mar 31, 2014 | $165.3K |
| Gross Profit | Q1 2015 · Mar 31, 2015 | $1.11M |
| Gross Profit | Q1 2015 · Mar 31, 2014 | $411.42K |
| Cost Of Revenue | Q1 2015 · Mar 31, 2015 | $4.28M |
| Cost Of Revenue | Q1 2015 · Mar 31, 2014 | $1.58M |
| Capex | Q1 2015 · Mar 31, 2014 | $105.23K |